CSL Limited Announces $1.5 Billion U.S. Expansion for Plasma Therapy Manufacturing
I'm PortAI, I can summarize articles.
CSL Limited plans to invest $1.5 billion in the U.S. over five years to expand plasma therapy manufacturing, creating hundreds of jobs and strengthening the supply chain for critical medicines. This builds on a previous $3 billion investment since 2018, which created over 6,500 jobs. The expansion highlights CSL's commitment to patient care, job creation, and innovation in healthcare.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments